12-66138166-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016056.4(TMBIM4):c.511T>C(p.Phe171Leu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/15 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_016056.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMBIM4 | NM_016056.4 | c.511T>C | p.Phe171Leu | missense_variant, splice_region_variant | 7/7 | ENST00000358230.8 | NP_057140.2 | |
TMBIM4 | NM_001282606.2 | c.652T>C | p.Phe218Leu | missense_variant, splice_region_variant | 8/8 | NP_001269535.1 | ||
TMBIM4 | NM_001282610.2 | c.418T>C | p.Phe140Leu | missense_variant, splice_region_variant | 7/7 | NP_001269539.1 | ||
TMBIM4 | NM_001282609.2 | c.476T>C | p.Val159Ala | missense_variant, splice_region_variant | 7/7 | NP_001269538.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMBIM4 | ENST00000358230.8 | c.511T>C | p.Phe171Leu | missense_variant, splice_region_variant | 7/7 | 1 | NM_016056.4 | ENSP00000350965.3 | ||
ENSG00000228144 | ENST00000539652.1 | n.465-37T>C | intron_variant | 2 | ENSP00000454670.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 27, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at